Home›Stock Screener›Trimurthi›Intrinsic Value

Trimurthi Intrinsic Value

Trimurthi intrinsic value. Trimurthi (NOVELIX) median intrinsic value is ₹19.61 from 3 valuation models (range ₹13–₹34), vs current price ₹65.37 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Analyse Trimurthi ownership structure to track promoter, FII and institutional holdings.

Market Price (CMP)
₹65.37
Primary Intrinsic Value
₹13.07
Market Cap
₹52.3 Cr
-70.0% Downside
Median Value
₹19.61
Value Range
₹13 - ₹34
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

NOVELIX Valuation Methods Summary — DCF, Graham Number & P/E

Trimurthi intrinsic value across 3 models vs current price ₹65.37 — upside/downside and value range per method. For current market price and key ratios, visit Trimurthi stock price NSE.

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹13.07 ₹11.76 - ₹14.38 -80.0% Book Value/Share: ₹10.00, P/B: 1.0x
Revenue Multiple Method revenue ₹19.61 ₹17.65 - ₹21.57 -70.0% Revenue/Share: ₹5.00, P/S: 0.8x
Simple DCF (5Y) dcf ₹33.96 ₹27.17 - ₹40.75 -48.0% CF Growth: 15.0%, Discount: 15%
Method Types: Earnings Asset DCF Growth Dividend Conservative

NOVELIX Intrinsic Value vs Market Price — All Valuation Models

Trimurthi fair value range ₹13–₹34 vs current market price ₹65.37 across 3 valuation models. Browse Trimurthi financial data for revenue, profit, balance sheet and cash flow data.

NOVELIX Intrinsic Value Analysis — Undervalued or Overvalued?

Trimurthi median intrinsic value ₹19.61, current price ₹65.37 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.

What is the intrinsic value of NOVELIX?

Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Trimurthi (NOVELIX) is ₹19.61 (median value). With the current market price of ₹65.37, this represents a -70.0% variance from our estimated fair value.

The valuation range spans from ₹13.07 to ₹33.96, indicating ₹13.07 - ₹33.96.

Is NOVELIX undervalued or overvalued?

Based on our multi-method analysis, Trimurthi (NOVELIX) appears to be trading above calculated value by approximately 70.0%.

NOVELIX Financial Health — Key Ratios vs Industry Benchmarks

Trimurthi financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Operating Margin -15.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 0.44x Industry Standard: 1.0x+ Below 0.5x Measures asset utilization efficiency

NOVELIX Cash Flow Quality — Operating & Free Cash Flow

Trimurthi operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2022 ₹2 Cr ₹2 Cr Positive Free Cash Flow 8/10
March 2021 ₹2 Cr ₹2 Cr Positive Free Cash Flow 8/10
March 2020 ₹1 Cr ₹1 Cr Positive Free Cash Flow 8/10
March 2019 ₹-1 Cr ₹-1 Cr Negative Cash Flow 3/10
March 2018 ₹0 Cr ₹-1 Cr Negative Cash Flow 3/10